AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor
about
Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase.Activation of TRAP/mediator subunit TRAP220/Med1 is regulated by mitogen-activated protein kinase-dependent phosphorylationA novel inducible transactivation domain in the androgen receptor: implications for PRK in prostate cancerExpression of RAC 3, a steroid hormone receptor co-activator in prostate cancerLoss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancerMir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNAAdvances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapyEndocrinology and hormone therapy in breast cancer: new insight into estrogen receptor-alpha function and its implication for endocrine therapy resistance in breast cancerFrom bench to bedside: What do we know about hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer?Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistanceSKF-82958 is a subtype-selective estrogen receptor-alpha (ERalpha ) agonist that induces functional interactions between ERalpha and AP-1Concerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/NeuNuclear receptor coactivators: the key to unlock chromatinSerine 28 phosphorylation of NRIF3 confers its co-activator function for estrogen receptor-alpha transactivationRole of nuclear receptor coactivator 3 (Ncoa3) in pluripotency maintenanceHistone acetylation and steroid receptor coactivator expression during clofibrate-induced rat hepatocarcinogenesisDecreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions.Regulation of SRC-3 intercompartmental dynamics by estrogen receptor and phosphorylation.Suppression of androgen receptor transactivation by Pyk2 via interaction and phosphorylation of the ARA55 coregulator.Genomics of signaling crosstalk of estrogen receptor alpha in breast cancer cells.Activation of estrogen receptor-alpha by E2 or EGF induces temporally distinct patterns of large-scale chromatin modification and mRNA transcription.Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance.Global characterization of transcriptional impact of the SRC-3 coregulatorShort-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition.EGFRvIII-induced estrogen-independence, tamoxifen-resistance phenotype correlates with PgR expression and modulation of apoptotic molecules in breast cancer.Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor.Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity.Proteomic analysis of pathways involved in estrogen-induced growth and apoptosis of breast cancer cells.Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) familyRapid estrogen-induced phosphorylation of the SRC-3 coactivator occurs in an extranuclear complex containing estrogen receptorCross-talk between HER2 and MED1 regulates tamoxifen resistance of human breast cancer cells.Peptidyl-prolyl isomerase 1 (Pin1) serves as a coactivator of steroid receptor by regulating the activity of phosphorylated steroid receptor coactivator 3 (SRC-3/AIB1).Phosphorylation of AIB1 at mitosis is regulated by CDK1/CYCLIN B.Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling.The nuclear receptor interaction domain of GRIP1 is modulated by covalent attachment of SUMO-1.Growth factor stimulation induces a distinct ER(alpha) cistrome underlying breast cancer endocrine resistanceRole of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer.The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer.Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer.
P2860
Q24295084-7807933B-9A9A-434F-B99D-9D6E92D6C230Q24297166-B6A5C734-4D2A-4598-AAAE-DE59ABD34572Q24338270-8928110F-B57B-4C57-BA43-E5F67DEB59F4Q24648557-F6564D30-99A2-474C-BDBE-0E1FE2280BE9Q24653934-DB817303-4D79-4AF9-A374-5F50B628205DQ24672429-E696AC77-F756-4F4B-B9AB-239234F70D93Q24803990-04ABCD14-6E44-4421-8CFB-5D2FDE1D917BQ24813627-8E41FE69-7EEA-4114-AC7F-5213BBE49253Q28084982-974F1067-0798-4FFC-9B32-62FBE1D122A3Q28141690-E17DE9CE-06E7-4142-98FE-E5D0F1B142D2Q28204373-B16BFE2B-8E4A-4CF5-9FB8-3F98A0602984Q28241103-8F0ECF17-420D-434F-9531-0F10F3E33196Q28266740-D5BAD777-8830-4B0A-9FA4-BEA42DB127D8Q28282462-B0F523DE-CE10-4D61-A798-F7163BD26A1DQ28512586-76C617CA-03ED-4D72-B163-133AF368E1C3Q28577672-A255728A-336D-49BD-BF21-A5E74D511B34Q30439093-86196EDD-5022-4B49-A7C8-66B97FB0DD48Q30480773-B9AEC3C7-BD8C-4260-BB75-B0900CDABE8FQ30816464-ADC3BD53-F46B-46DA-9B2C-DC2FAB376CC2Q33325484-920A50D9-D930-4CD0-8AA4-D72FD792D7A0Q33338444-B8959841-8321-4DB6-90C6-2D565C493729Q33648503-24CA1E18-1FB1-44CD-9814-DBE65B0E76CCQ33780217-85A460AB-F36D-4354-86B6-A9B76A643B6EQ33783545-E0F50195-F81E-43C9-A6FE-7B718E301DB1Q33793142-53A20643-64F2-40B8-9E4A-F911BE1FCB7DQ33903965-2B547B32-AB05-47A5-94D1-B013D6ECB603Q33933516-98F0EBB3-AF2C-499A-978B-D481F4B5FB2BQ33940612-29F5EB6F-EBD2-4840-81F0-B29FFADFCF8FQ33954542-295D2169-CD45-4AC1-9F78-AF2B93EBE0BCQ34013708-E41DAEE1-DEAD-4E0F-9018-9F67D640D5DFQ34042838-7E4E0222-EB30-4472-83B8-0F37691E8C98Q34077845-0DF16D8A-87BF-47C3-BCED-4C88A172BE25Q34097347-999E1716-E21F-4E9C-B0A5-57C8972569B2Q34098262-FC19B03C-F693-4990-AE5E-580C035B245AQ34125163-6A509739-39DC-4573-A219-2926E876B6EAQ34132954-E60C548E-8EBD-4AD1-95AA-C33D9385D404Q34164930-40BC7079-0D06-4495-B42E-ED25F09B1FBBQ34181456-EE6B826B-0849-4D7E-8BCA-7869065D33CBQ34286419-46F28000-5085-4B75-AB79-29AF718799B6Q34306286-6A56B213-BC62-4286-9353-0BF544BDFF79
P2860
AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor
@ast
AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor
@en
AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor
@en-gb
AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor
@nl
type
label
AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor
@ast
AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor
@en
AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor
@en-gb
AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor
@nl
prefLabel
AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor
@ast
AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor
@en
AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor
@en-gb
AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor
@nl
P2860
P1476
AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor
@en
P2093
J Font de Mora
P2860
P304
P356
10.1128/MCB.20.14.5041-5047.2000
P407
P577
2000-07-01T00:00:00Z